Skip to main content

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024

WOBURN, MA / ACCESSWIRE / March 8, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three and 12 months ended December 31, 2023 on Friday, March 15, 2024. The results will be released after the market close on Friday, March 15 and the company will host a conference call on Monday, March 18 at 10:00am Eastern Time.

Conference Call and Webcast Information

Conference call: Monday, March 18, 2024 at 10:00 AM Eastern Time
Toll Free: 1-877-877-1275
International: 1-412-858-5202
Webcast: Webcast | Fourth Quarter 2023 Financial Results and Business Update Conference Call (

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit


Investor Relations
Andrew Barwicki

SOURCE: Biofrontera Inc.

View the original press release on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.